SCHEMBL25645971

SCHEMBL25645971

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5cccc6sc7ccccc7c56)cc4)nc(-c4cccc5oc6ccccc6c45)n3)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.35
LIMK1 P53667 1/20 0.34
MAPT P10636 5/20 0.34
ALDH1A1 P00352 4/20 0.33
TSHR P16473 4/20 0.33
KDM4E B2RXH2 3/20 0.33
HSD17B10 Q99714 3/20 0.33
MAPK1 P28482 2/20 0.33
HPGD P15428 2/20 0.33
ATM Q13315 2/20 0.33
TP53 P04637 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
POLB P06746 1/20 0.33
BRDT Q58F21 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23821618 1.00 BACE1 (0.35) BACE1LIMK1MAPTALDH1A1TSHR
SCHEMBL23820794 0.99 BACE1 (0.36) BACE1LIMK1MAPTALDH1A1TSHR
SCHEMBL25645973 0.95 BRDT (0.34) BACE1LIMK1MAPTALDH1A1TSHR
SCHEMBL23820933 0.95 BRDT (0.35) BACE1LIMK1MAPTALDH1A1TSHR
SCHEMBL19802388 0.95 MAPT (0.36) BACE1LIMK1MAPTALDH1A1TSHR
SCHEMBL22763926 0.94 LIMK1 (0.35) BACE1LIMK1MAPTALDH1A1TSHR
SCHEMBL23821088 0.94 BACE1 (0.33) BACE1LIMK1MAPTALDH1A1TSHR
SCHEMBL23820294 0.93 PRKDC (0.35) BACE1LIMK1MAPTALDH1A1TSHR
SCHEMBL23820482 0.93 S1PR5 (0.36) BACE1LIMK1MAPTALDH1A1TSHR
SCHEMBL23820792 0.93 BRDT (0.35) BACE1LIMK1MAPTALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165145-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165145-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, CYP1A1, CYP1B1 BACE1 134/4885LIMK1 199/4885MAPT 700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.